A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.
Read More
Mazen Animal Health, an Iowa-based agricultural biotechnology company with a new research-and-development center in Research Triangle Park, has received a patent for its technology to produce orally delivered animal vaccines.
Read More
Biomedical engineers at Duke University have developed a tablet-based vaccine for urinary tract infections (UTIs) that rapidly dissolves when placed under the tongue. The new treatment could offer an easy and practical alternative to high-dose, oral antibiotics which are the current standard for UTI treatments.
Read More
A report by an expert panel, arguing that a comprehensive, coordinated approach is required to enhance global influenza vaccine supply chain infrastructure, manufacturing, distribution and administration.
Read More
People should consider getting their vaccine boosters eight months after they received their second dose of Pfizer or Moderna to fight COVID-19. But what are booster shots? And why are they needed?
Read More
Three coronavirus vaccines are currently in use. But one that’s about to start phase three trials across the United States, including right here in the Triangle, could be a game changer.
Read More
Having trouble scoring a COVID-19 vaccine appointment? You’re not alone. To cope, some people are turning to bots that scan overwhelmed websites and send alerts on social media when slots open up.
Read More
How big is the problem of COVID variants? Can vaccine manufacturers keep up?
Read More
The United Kingdom on Wednesday become the first country to approve the coronavirus vaccine developed by Oxford University and AstraZeneca. The shot is cheaper and easier to distribute than alternatives, and is expected to play a crucial role in boosting the global economy next year.
Read More
